Hannah Deresiewicz
Investor Relations Contact presso FORTY SEVEN, INC.
Posizioni attive di Hannah Deresiewicz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FORTY SEVEN, INC. | Investor Relations Contact | - | - |
| KALA BIO, INC. | Investor Relations Contact | - | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/06/2013 | - |
Storia della carriera di Hannah Deresiewicz
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Hannah Deresiewicz
- Esperienza
